Katarzyna Wawrzycka-Adamczyk Selected Research

Katarzyna Wawrzycka-Adamczyk Research Topics

7	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2022 - 01/2014
2	Vasculitis (Vasculitides) 05/2022 - 01/2014
2	Inflammation (Inflammations) 03/2022 - 01/2021
1	Systemic Vasculitis 03/2019
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2016
1	Chronic Renal Insufficiency 10/2015
1	Hearing Loss (Hearing Impairment) 10/2015
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2014
1	Lymphoma (Lymphomas) 01/2014

4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 01/2014
2	MicroRNAs (MicroRNA)IBA 03/2022 - 10/2015
1	Myeloblastin (Proteinase 3)IBA 03/2022
1	AntibodiesIBA 03/2022
1	Thrombin FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ThrombomodulinIBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	5-oxo-eicosatetraenoic acidIBA 01/2020
1	Leukotriene B4IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 05/2016
1	GlucocorticoidsIBA 10/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Rituximab (Mabthera)FDA Link 01/2014

1	Laryngectomy 01/2016
1	Remission Induction 01/2014